Effect of estrogen on natural killer cells.
Treatment of mice with sustained high levels of betarestradiol leads to a reduction in natural killer cell activity and genetic resistance to bone marrow transplantation. The loss of natural killing does not seem to result from either humoral or immune suppression. Natural killer cells are thought to depend on the bone marrow, and it is notable that estrogens reduce natural killing at approximately the same time that they produce a loss of ma-row due to osteoproliferation. Similarly, mice with congenital osteopetrosis are deficient in natural killing. However, changes in natural killing during and after treatment with estrogen do not correspond directly to changes in marrow volume. Estrogens are known to exacerbate spontaneous autoimmunity in NZB/NZW mice. The relationship between this  effect and the effect of estrogen on natural killing is not clear. When natural killing is lowered in NZB/NZW mice by the in vivo administration of 89Sr, autoimmunity is reduced.
D000818:Animals; D001853:Bone Marrow / Q000187:drug effects / Q000254:growth & development; D016026:Bone Marrow Transplantation; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004958:Estradiol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D006084:Graft Rejection; D007694:Killer Cells, Natural / Q000187:drug effects*; D008297:Male; D051379:Mice; D013154:Spleen / Q000601:surgery; D014184:Transplantation, Homologous
D004967:Estrogens; D004958:Estradiol